arrow
A

Anna Maria Zeitlberger

department of neurosurgery
H指数:13
被引数:469

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gliamimic: a longitudinal, multimodal in vitro platform for evaluating glioblastoma treatment response and post-treatment tumor progression in patient-derived organoids or spheroids

Gliamimic:一种纵向、多模式体外平台,用于评估胶质母细胞瘤治疗反应及患者来源类器官或球体的治疗后肿瘤进展

2026-09-010
OA
Clinical Implementation and Oncological Relevance of Molecular Profiling in Brain Metastases Patients—A Multicenter Retrospective Cohort Study

脑转移瘤患者分子分型的临床实施与肿瘤学相关性——一项多中心回顾性队列研究

2026-06-180
OAAI
Postoperative absence of residual intracranial tumor volume is associated with improved survival and intracranial disease control in non-small cell lung cancer brain metastases

术后无残留颅内肿瘤体积与非小细胞肺癌脑转移瘤患者的生存改善和颅内疾病控制相关。

2025-12-220
OAAI
Pharmacoscopy-guided discovery of vortioxetine as a repurposable neuroactive therapeutic for glioblastoma

药理学显微镜指导下将沃利昔汀重新定位为可再利用的神经活性胶质母细胞瘤治疗药物

2025-11-010
OAAI
The intra-tumoral heterogeneity of T cell antigens in glioblastoma

胶质母细胞瘤中T细胞抗原的肿瘤内异质性

2025-11-010
OAAI
Prognostic value of the Therapy-Disability-Neurology (TDN) Scale for surgical adverse events in glioblastoma: a multi-center analysis

胶质母细胞瘤手术不良事件中治疗-残疾-神经学(TDN)量表预测价值的多中心分析

2025-11-010
OAAI
High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity
2024-09-200
OAAI